Insider · CIK 0001824121
Geoffrey Gates Scott
Files at AEHR (AEHR TEST SYSTEMS). First filing Apr 10, 2026, latest Aug 13, 2026.
In brief
Geoffrey Gates Scott files SEC Form 4 as director at AEHR (AEHR TEST SYSTEMS). Since Apr 10, 2026, Geoffrey Gates Scott has reported 0 open-market buys worth $0 and 5 open-market sells worth $15M, the latest filed on Aug 13, 2026.
A track record needs three past buys with six months of prices behind them; Geoffrey Gates Scott has 0, so none is measured yet.
The newest scored trade: sold $2.6M of AEHR on Aug 12, 2026, filed Aug 13, 2026, scored 75 (notable). In the last 12 months: 0 buys worth $0 and 5 sells worth $15M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AEHR: AEHR TEST SYSTEMS
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 75Notable | AEHR TEST SYSTEMS | $2.6M 20,000 shares | -67% | +644% from low0% from high | |
| 50Moderate | AEHRsell AEHR TEST SYSTEMS | $1.6M 20,000 shares | -40% | +470% from low-28% from high | |
| 75Notable | AEHR TEST SYSTEMS | $5.7M 60,000 shares | -99% | +1077% from low0% from high | |
| 65Notable | AEHR TEST SYSTEMS | $2.7M 40,000 shares | -29% | +765% from low0% from high | |
| 65Notable | AEHR TEST SYSTEMS | $2.4M 35,000 shares | -25% | +765% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 12, 2026 | AEHR AEHR TEST SYSTEMS | 20,000 0.06% of outstanding | $2.6M | Aug 12, 2026 | $1.6M |
| Jul 16, 2026 | AEHR AEHR TEST SYSTEMS | 20,000 0.06% of outstanding | $1.6M | Jul 16, 2026 | none |
| Apr 21, 2026 | AEHR Aehr Test Systems | 10,000 0.03% of outstanding | $910k | Apr 21, 2026 | $2.7M |
| Apr 21, 2026 | AEHR Aehr Test Systems | 50,000 0.16% of outstanding | $4.7M | Apr 22, 2026 | $3.6M |
| Apr 9, 2026 | AEHR AEHR Test Systems | 40,000 0.13% of outstanding | $2.7M | Apr 9, 2026 | none |
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | AEHR AEHR TEST SYSTEMS | GGift Common Stockindirect: By Trust | -6,731 | $0.00 | $0 | 23,955 | Aug 13, 2026 |
| Aug 12, 2026 | AEHR AEHR TEST SYSTEMS | SOpen-market sale Common Stockindirect: By Spouse | -20,000 | $131.51 | $2.6M | 10,000 | Aug 13, 2026 |
| Jul 21, 2026 | AEHR AEHR TEST SYSTEMS | GGift Common Stock | -2,874 | $0.00 | $0 | 51,648 | Jul 21, 2026 |
| Jul 16, 2026 | AEHR AEHR TEST SYSTEMS | GGift Common Stockindirect: By Trust | -10,000 | $0.00 | $0 | 30,686 | Jul 17, 2026 |
| Jul 16, 2026 | AEHR AEHR TEST SYSTEMS | SOpen-market sale Common Stockindirect: By Spouse | -20,000 | $82.13 | $1.6M | 30,000 | Jul 17, 2026 |
| Jul 1, 2026 | AEHR AEHR TEST SYSTEMS | AGrant or award Common Stock | +1,658 | $0.00 | $0 | 54,522 | Jul 2, 2026 |
| Apr 29, 2026 | AEHR AEHR TEST SYSTEMS | GGift Common Stockindirect: By Trust | -10,000 | $0.00 | $0 | 40,686 | May 13, 2026 |
| Apr 29, 2026 | AEHR AEHR TEST SYSTEMS | FTax withholding Common Stockindirect: By Trust | -10,000 | $0.00 | $0 | 40,686 | Apr 29, 2026 |
| Apr 21, 2026 | AEHR AEHR TEST SYSTEMS | SOpen-market sale Common Stockindirect: By Trust | -10,000 | $91.00 | $910k | 50,686 | Apr 21, 2026 |
| Apr 21, 2026 | AEHR AEHR TEST SYSTEMS | SOpen-market sale Common Stockindirect: By Spouse | -50,000 | $95.00 | $4.8M | 50,000 | Apr 21, 2026 |
| Apr 9, 2026 | AEHR AEHR TEST SYSTEMS | SOpen-market sale Common Stockindirect: By Spouse | -5,000 | $68.00 | $340k | 135,000 | Apr 15, 2026 |
| Apr 9, 2026 | AEHR AEHR TEST SYSTEMS | SOpen-market sale Common Stockindirect: By Spouse | -25,000 | $68.12 | $1.7M | 110,000 | Apr 15, 2026 |
| Apr 9, 2026 | AEHR AEHR TEST SYSTEMS | SOpen-market sale Common Stockindirect: By Spouse | -10,000 | $67.79 | $678k | 100,000 | Apr 15, 2026 |
| Apr 9, 2026 | AEHR AEHR TEST SYSTEMS | SOpen-market sale Common Stockindirect: By Spouse | -5,000 | $68.00 | $340k | 135,000 | Apr 10, 2026 |
| Apr 9, 2026 | AEHR AEHR TEST SYSTEMS | SOpen-market sale Common Stockindirect: By Spouse | -25,000 | $67.75 | $1.7M | 110,000 | Apr 10, 2026 |
| Apr 9, 2026 | AEHR AEHR TEST SYSTEMS | SOpen-market sale Common Stockindirect: By Spouse | -5,000 | $67.90 | $340k | 105,000 | Apr 10, 2026 |
| Mar 10, 2026 | AEHR AEHR TEST SYSTEMS | GGift Common Stock | -5,104 | $0.00 | $0 | 52,864 | Mar 10, 2026 |
| Jul 2, 2025 | AEHR AEHR TEST SYSTEMS | AGrant or award Common Stock | +9,253 | $0.00 | $0 | 57,968 | Jul 3, 2025 |
| Oct 27, 2023 | AEHR AEHR TEST SYSTEMS | AGrant or award Common Stockindirect: by Trust | +4,460 | $0.00 | $0 | 65,146 | Oct 27, 2023 |
Questions about Geoffrey Gates Scott
Answered from the filings on this page, as of the latest one.
Is Geoffrey Gates Scott buying or selling?
In the last 12 months Geoffrey Gates Scott reported 0 open-market buys worth $0 and 5 open-market sells worth $15M on SEC Form 4; the latest was sold $2.6M of AEHR on Aug 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Geoffrey Gates Scott's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Geoffrey Gates Scott has 0.
Where does Geoffrey Gates Scott file Form 4?
Geoffrey Gates Scott has filed Form 4 at AEHR (AEHR TEST SYSTEMS) as Director. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.